Kwality Pharma Financials

BSE: 539997

₹4,115.50

up-down-arrow ₹-171.10 (-3.99%)

As on 20-Nov-2026 15:24IST

Market cap

info icon

₹4,312 Cr

Revenue (TTM)

info icon

₹624 Cr

P/E Ratio

info icon

44.9

P/B Ratio

info icon

11.2

Div. Yield

info icon

0 %

Income Statement (₹ Cr)

TTM Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17
Operating Revenue
624.13
503.08
370.20
307.17
251.03
456.19
Total Income
627.11
505.94
372.12
309.00
253.97
459.70
Total Expenditure
464.60
384.84
289.81
240.86
190.30
284.52
EBITDA
159.53
118.24
80.39
66.31
60.73
171.66
Depreciation
20.44
19.81
18.29
19.56
14.96
10.69
EBIT
139.09
98.43
62.10
46.75
45.77
160.97
Interest
11.03
10.97
9.88
10.39
6.61
2.92
Other Income
2.98
2.86
1.92
1.83
2.94
3.51
Exceptional Items
-0.83
-0.83
--
-7.10
-16.53
--
Profit before Tax
130.22
89.49
54.14
31.10
25.57
161.57
Provision for Tax
34.26
22.15
14.34
7.48
6.29
41.63
Profit after Tax
95.96
67.35
39.80
23.62
19.28
119.94
Minority Interest
--
0.00
0.04
0.18
0.09
0.05
Share of Associate
--
--
--
--
--
--
Consolidated Profit
95.96
67.35
39.85
23.80
19.37
119.99

Liabilities (₹ Cr)

TTM Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17
Shareholder's Funds
386.20
331.60
264.05
224.21
200.52
181.14
Minority Interest
--
-1.67
-1.65
-1.63
-1.45
-1.35
Non-Current Liabilities
52.41
34.27
13.76
19.75
28.62
21.32
Current Liabilities
260.88
225.52
169.51
151.85
125.95
139.49
Total Liabilities
697.82
592.21
447.27
394.21
353.63
340.59

Assets (₹ Cr)

TTM Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17
Non-Current Assets
201.31
184.03
161.88
151.49
146.43
112.77
Current Assets
480.45
405.68
283.78
242.69
207.20
227.82
Total Assets
697.82
592.21
447.27
394.21
353.63
340.59
Total Debt*
--
130.46
112.45
98.12
90.26
54.01
Net Current Assets
219.57
180.16
114.27
90.84
81.25
88.33
Contingent Liabilities
--
36.98
36.98
0.35
0.51
0.05

Cashflow (₹ Cr)

TTM Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17
Cash From Operating Activities
--
16.59
52.72
42.98
41.38
60.60
Cash Flow from Investing Activities
--
-34.91
-28.52
-26.40
-48.44
-62.93
Cash from Financing Activities
--
7.04
-14.44
-17.40
0.99
5.66
Net Cash Inflow / Outflow
--
-11.28
9.76
-0.81
-6.07
3.33

Financials Ratios

TTM Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17
Adjusted EPS (₹) info
93.05
64.90
38.40
22.93
18.67
115.64
Cash EPS (₹) info
92.48
84.00
55.99
41.61
33.00
125.89
Adjusted Book Value (₹) info
371.43
318.80
253.70
215.31
192.48
173.81
Dividend per Share (₹) info
--
--
--
--
--
--
Cash Flow per Share (₹) info
--
15.98
50.81
41.42
39.88
58.40
Free Cash Flow per Share (₹) info
--
-43.55
18.75
-9.74
-11.97
2.22

Profitability Ratios

TTM Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17
ROCE (%) info
--
24.01
18.36
13.57
12.27
97.93
ROE (%) info
26.90
22.67
16.36
11.16
10.15
99.66
ROA (%) info
16.33
13.01
9.48
6.32
5.55
47.33
EBIT Margin (%) info
22.29
19.57
16.77
15.22
18.23
35.29
Net Margin (%) info
15.30
13.31
10.70
7.64
7.59
26.09
Cash Profit Margin (%) info
--
17.32
15.69
14.06
13.64
28.64

Growth Ratios

TTM Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17
Revenue Growth (%) info
47.68
35.90
20.52
22.36
-44.97
74.11
EBIT Growth (%) info
89.12
58.51
32.82
2.16
-71.57
619.93
Net Profit Growth (%) info
96.68
69.20
68.54
22.49
-83.93
705.63
EPS Growth (%) info
95.47
69.02
67.44
22.83
-83.86
692.23
Book Value Growth (%) info
--
25.66
17.83
11.86
10.74
198.82

Valuation Ratios

TTM Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17
Price / Earnings info
44.94
20.13
22.63
17.85
16.47
5.02
Price / Book Value info
11.19
4.10
3.43
1.90
1.60
3.34
Dividend Yield (%) info
--
--
--
--
--
--
EV/EBITDA info
27.40
12.24
12.14
7.59
6.31
3.67
Close Price (₹) info
3,641.40
1,306.35
869.05
409.40
307.55
580.00
High Price (₹) info
3,949.00
1,740.00
1,069.95
545.00
638.95
1,117.00
Low Price (₹) info
828.80
666.00
414.00
248.00
265.60
53.00
Market Cap (₹ Cr) info
4,311.93
1,355.51
901.73
424.79
319.11
601.82

Solvency Ratios

TTM Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17
Debt to Equity info
0.10
0.39
0.43
0.44
0.45
0.30
Short term debt to equity ratio info
--
0.26
0.32
0.29
0.25
0.13
Current Ratio info
1.84
1.80
1.67
1.60
1.65
1.63
Quick Ratio info
1.56
1.45
1.18
1.08
0.96
1.25
Interest Coverage info
12.81
9.16
6.48
3.99
4.87
56.38

Operating Efficiency Ratios

TTM Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17
Debtors to sales (%) info
53.68
55.67
41.68
37.24
28.56
15.15
Asset Turnover info
1.06
0.97
0.88
0.82
0.72
1.80
Receivable days info
--
157.57
132.46
110.56
102.38
41.94
Inventory Days info
--
58.67
79.79
97.85
101.54
28.29
Payable days info
--
160.16
157.23
161.90
183.20
78.14
Cash Conversion Cycle info
--
56.07
55.02
46.51
20.73
-7.91
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
loading...
loading...

Informed fund ideas, better judgment. Every month. Mutual Fund Insight, every month since October 2002.

Take charge. Know more. Keep more. Mutual Fund Insight helps you do all three — every month